History and future of RNA medicines.
Hovnanian A, Mondon G, Titeux M
Journal of Investigative DermatologyIn the feed 8 Jul 2026, published online 7 Jul 2026, issue 2026 Jul 07, added to PubMed 8 Jul 2026
Topics: Genetic skin diseasePractice, education & research
Abstract
RNA therapeutics are a versatile class of medicines that exploit different types of RNA molecules to prevent or treat a wide spectrum of diseases. Compared with traditional small-molecule drugs, protein drugs, or gene therapies, these therapies offer notable advantages, including faster, less expensive development, and simplified manufacturing. The field encompasses multiple modalities, such as antisense oligonucleotides, small interfering RNAs, microRNAs, mRNAs, and aptamers. The success of mRNA vaccines against SARS-CoV-2 has accelerated research and clinical translation of RNA approaches for conditions with limited treatment options, including chronic wounds, aggressive metastatic melanoma, and autoimmune and genetic skin diseases.
Abstract from PubMed
PMID 42417685 · DOI 10.1016/j.jid.2026.05.023